EGFR and hepatocellular carcinoma: Moreover, the blockade of EGFR signaling with gefitinib EGFR inhibitor also prevents DEN‐induced liver carcinogenesis in rats and inhibits the proliferation of human HCC cell lines Huh‐7 and HepG2 in vitro.78, 79